Cerebrospinal fluid IL-6, HSP72, and TNF-α in exercising humans

Brain, Behavior, and Immunity

Volumn 20, Issue 6, 2006, Pages 585-589

  Steensberg, Adam ^a   Dalsgaard, Mads K ^a   Secher, Niels H ^a   Pedersen, Bente Klarlund ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Blood brain barrier; CNS; CSF; Cytokines; Exercise; Obesity

Indexed keywords

HEAT SHOCK PROTEIN 72; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CARBOHYDRATE DIET; CEREBROSPINAL FLUID; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; EXERCISE; HUMAN; LUMBAR PUNCTURE; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; BLOOD-BRAIN BARRIER; DIETARY CARBOHYDRATES; EXERCISE; HSP72 HEAT-SHOCK PROTEINS; HUMANS; INTERLEUKIN-6; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33749681126     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2006.03.002     Document Type: Article

References (27)

1. Asea A., Kraeft S.K., Kurt-Jones E.A., Stevenson M.A., Chen L.B., Finberg R.W., Koo G.C., and Calderwood S.K. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6 (2000) 435-442
2. Banks W.A., Kastin A.J., and Gutierrez E.G. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett. 179 (1994) 53-56
3. Banks W.A., Kastin A.J., and Broadwell R.D. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2 (1995) 241-248
4. Benveniste E.N. Cytokine actions in the central nervous system. Cytokine Growth Factor Rev. 9 (1998) 259-275
5. Campisi J., Leem T.H., Greenwood B.N., Hansen M.K., Moraska A., Higgins K., Smith T.P., and Fleshner M. Habitual physical activity facilitates stress-induced HSP72 induction in brain, peripheral, and immune tissues. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284 (2003) R520-R530
6. Febbraio M.A., and Pedersen B.K. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J. 16 (2002) 1335-1347
7. Febbraio M.A., Ott P., Nielsen H.B., Steensberg A., Keller C., Krustrup P., Secher N.H., and Pedersen B.K. Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. J. Physiol. 544 (2002) 957-962
8. Febbraio M.A., Hiscock N., Sacchetti M., Fischer C.P., and Pedersen B.K. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes 53 (2004) 1643-1648
9. Fehrenbach E., Niess A.M., Voelker K., Northoff H., and Mooren F.C. Exercise intensity and duration affect blood soluble HSP72. Int. J. Sports Med. 26 (2005) 552-557
10. Guzhova I., Kislyakova K., Moskaliova O., Fridlanskaya I., Tytell M., Cheetham M., and Margulis B. In vitro studies show that Hsp70 can be released by glia and that exogenous Hsp70 can enhance neuronal stress tolerance. Brain Res. 914 (2001) 66-73
11. Jablons D.M., Mule J.J., McIntosh J.K., Sehgal P.B., May L.T., Huang C.M., Rosenberg S.A., and Lotze M.T. IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans. J. Immunol. 142 (1989) 1542-1547
12. Joseph J., Grun J.L., Lublin F.D., and Knobler R.L. Interleukin-6 induction in vitro in mouse brain endothelial cells and astrocytes by exposure to mouse hepatitis virus (MHV-4, JHM). J. Neuroimmunol. 42 (1993) 47-52
13. Lancaster G.I., Moller K., Nielsen B., Secher N.H., Febbraio M.A., and Nybo L. Exercise induces the release of heat shock protein 72 from the human brain in vivo. Cell Stress. Chaperones 9 (2004) 276-280
14. McCann S.M., Karanth S., Kamat A., Les D.W., Lyson K., Gimeno M., and Rettori V. Induction by cytokines of the pattern of pituitary hormone secretion in infection. Neuroimmunomodulation 1 (1994) 2-13
15. Nieman D.C., Nehlsen-Cannarella S.L., Fagoaga O.R., Henson D.A., Utter A., Davis J.M., Williams F., and Butterworth D.E. Influence of mode and carbohydrate on the cytokine response to heavy exertion. Med. Sci. Sports Exerc. 30 (1998) 671-678
16. Nybo L., Nielsen B., Pedersen B.K., Moller K., and Secher N.H. Interleukin-6 release from the human brain during prolonged exercise. J. Physiol. 542 (2002) 991-995
17. Porter J.C., Sissom J.F., Arita J., and Reymond M.J. Hypothalamic-hypophysial vasculature and its relationship to secretory cells of the hypothalamus and pituitary gland. Vitam. Horm. 40 (1983) 145-174
18. Robson-Ansley P.J., de Milander L., Collins M., and Noakes T.D. Acute interleukin-6 administration impairs athletic performance in healthy, trained male runners. Can. J. Appl. Physiol 29 (2004) 411-418
19. Spangelo B.L., Isakson P.C., and MacLeod R.M. Production of interleukin-6 by anterior pituitary cells is stimulated by increased intracellular adenosine 3′,5′-monophosphate and vasoactive intestinal peptide. Endocrinology 127 (1990) 403-409
20. Spangelo B.L., Judd A.M., MacLeod R.M., Goodman D.W., and Isakson P.C. Endotoxin-induced release of interleukin-6 from rat medial basal hypothalami. Endocrinology 127 (1990) 1779-1785
21. Steensberg A., van Hall G., Osada T., Sacchetti M., Saltin B., and Klarlund P.B. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J. Physiol. 529 (2000) 237-242
22. Stenlof K., Wernstedt I., Fjallman T., Wallenius V., Wallenius K., and Jansson J.O. Interleukin-6 levels in the central nervous system are negatively correlated with fat mass in overweight/obese subjects. J. Clin. Endocrinol. Metab. 88 (2003) 4379-4383
23. Stouthard J.M., Romijn J.A., Van der P.T., Endert E., Klein S., Bakker P.J., Veenhof C.H., and Sauerwein H.P. Endocrinologic and metabolic effects of interleukin-6 in humans. Am. J. Physiol. 268 (1995) E813-E819
24. Tsigos C., Papanicolaou D.A., Defensor R., Mitsiadis C.S., Kyrou I., and Chrousos G.P. Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology 66 (1997) 54-62
25. van Hall G., Steensberg A., Sacchetti M., Fischer C., Keller C., Schjerling P., Hiscock N., Moller K., Saltin B., Febbraio M.A., and Pedersen B.K. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J. Clin. Endocrinol. Metab. 88 (2003) 3005-3010
26. Wallenius V., Wallenius K., Ahren B., Rudling M., Carlsten H., Dickson S.L., Ohlsson C., and Jansson J.O. Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 8 (2002) 75-79
27. Weber J., Yang J.C., Topalian S.L., Parkinson D.R., Schwartzentruber D.S., Ettinghausen S.E., Gunn H., Mixon A., Kim H., and Cole D. Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J. Clin. Oncol. 11 (1993) 499-506